Prostate Cancer Topics

Welcome to Prostate-Cancer.On-Topic.net!

Introducing Prostate Cancer Topics. At Prostate Cancer Topics you can browse our extensive library of accurate Prostate Cancer information and terminology. From A1 to Zoladex® and everything in between, you can be confident that Prostate Cancer Topics will provide you free and easily accessible accurate Prostate Cancer information and terminology.

Prostate Cancer Topics combines terminology, facts, timely related news stories and user submitted links to create offer a comprehensive "Prostate Cancer" resource. In addition to the reference material provided by Prostate Cancer Topics you can always research your favorite topics off-site using our helpful one-click research links and related website links.

Prostate Cancer Word of the Day

The Prostate Cancer Word of the Day is Diabetes Mellitus. Diabetes Mellitus in context to Prostate Cancer means:

A severe, chronic form of diabetes caused by insufficient production of insulin and resulting in abnormal metabolism of carbo ... Read More

Prostate Cancer News

DGCRF: PCA3 Prostate Cancer Test Featured in Journal of Urology (Nasdaq)
DiagnoCure Inc. (DGCRF) announced that PCA3, the Company's highly specific prostate cancer marker, is featured in an article in the November issue of the Journal of Urology. The new published study supports the use of a PCA3-based test as a tool for better assessing the prognosis of prostate cancer. Read More

A new study supports the prognostic value of the PCA3 prostate cancer marker (CNW Group via Yahoo! Finance)
DiagnoCure Inc. , a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, reported today that PCA3, the Company's highly specific prostate cancer marker, is featured in an important article in the November issue of the Journal of Urology. Read More

New risk factor for prostate cancer (PhysOrg)
(PhysOrg.com) -- The greater the levels of a protein called Insulin-like Growth Factor-1 (IGF-1), the greater the risk of prostate cancer, an Oxford University-led study has found. The results are published in the journal Annals of Internal Medicine. Read More

BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine (Medical News Today)
BN ImmunoTherapeutics has now evaluated the mature Phase II data from the therapeutic prostate cancer vaccine candidate PROSTVAC(TM) that had been obtained as part of the recently entered partnership with the National Cancer Institute (NCI) in the US. Read More

Researchers Provide New Insights Into Common Alterations Of ERG Oncogene In Prostate Cancer (Medical News Today)
In the past three years, ground-breaking discoveries in the prostate cancer field have highlighted that alterations of ETS related genes (predominantly ERG), as a result of a fusion between male hormone receptor regulated gene promoters (predominantly TMPRSS2) and ETS transcription factors, represent one of the most common oncogenic defects in prostate cancer. Read More

About Prostate Cancer Topics

Prostate Cancer Topics is a not-for-profit website dedicated to bringing accurate Prostate Cancer information and terminology.

Prostate Cancer Topics is part of the On-Topic Network. Read More